AstraZeneca tests new combo drugs in fight against obesity
NCT ID NCT07017179
Summary
This study is testing two new investigational drugs, AZD6234 and AZD9550, to see if they are safe and can help with weight loss in Chinese adults who have obesity or are overweight. Researchers will give the drugs separately and together to about 871 participants to compare their effects. The main goals are to check for side effects and measure how much body weight changes over 16 to 28 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGJinan, 250001, China
-
Research Site
RECRUITINGNanjing, 210011, China
-
Research Site
RECRUITINGShanghai, 200032, China
Conditions
Explore the condition pages connected to this study.